The role of Tadalafil in the treatment of BPH and ED. Tadalafil remains a safe and effective on-demand PDE5i for managing LUTS

01 Mar 2023
The role of Tadalafil in the treatment of BPH and ED. Tadalafil remains a safe and effective on-demand PDE5i for managing LU
Dr Surayne Segaran, a Consultant Urological Surgeon, discussed the prevalence of erectile dysfunction (ED), the role of PDE-5 inhibitors (PDE5i), its preference over alpha blockers as the first line treatment of lower urinary tract symptoms (LUTS), and the minimal side effects of tadalafil for on-demand dosing at a Novugen-sponsored forum.
Sponsored as an educational program by Novugen Pharma Sdn Bhd.

Resources

MY-NVG-002

MY-NVG-002

MY-NVG-002

MY-NVG-002